News and Events: Recent Highlights

Note:  TransMed7’s products are under development and are not yet commercially available.

5/2-6/2018:  TransMed7 highlighted its SpeedBird and Concorde technologies at the 2018 Annual Meeting of the American Society of Breast Surgeons.

5/1/2018:  TransMed7, LLC announced the appointment of National Sales Manager Greg Carpenter for Concorde MD, LLC.

4/11-15/2018:  TransMed7, LLC highlighted its SpeedBird, Concorde, and Cardinal technologies at the Annual Meeting of the Society of Breast Imaging in Las Vegas.

3/1/2018:  TransMed7 announced the appointment of Breast Health expert Jocelyn Rapelyea, M.D. to the company’s Clinical and Scientific Advisory Board (CSAB).

2/23/2018:  TransMed7 held a Key Opinion Leader (KOL) Symposium at the company’s new corporate offices in Phoenix, AZ.

1/22/2018:  TransMed7, LLC, today announced the addition of David Harding to its Business Advisory Board.

12/11/2017:  TransMed7, LLC today announced the creation of, and inaugural appointments to, its Business Advisory Board. 

11/7/2017:  TransMed7 receives U.S. Patent No. 9,808,226 for SpeedBird soft tissue biopsy platform technology.

10/17/2017:  TransMed7 announces 510(k) Submission to the FDA for its SpeedBird Soft Tissue Biopsy Device Platform.

10/10/2017:  TransMed7 announces the appointment of Michael J. Demeure, MD, MBA, as Chair of its Endocrine and Gastrointestinal (GI) Health Team and Member of its Executive Team of TransMed7’s Clinical and Scientific Advisory Board (CSAB).

9/25/2017:  TransMed7 announces the appointment of Richard E. Fine, MD, as Chair of its Breast Health Team and Member of its Executive Team of TransMed7’s Clinical and Scientific Advisory Board (CSAB).

9/11/2017:  TransMed7 announces a Strategic Partnership with Peridot Corporation effective August 21, 2017.

7/24/2017:  Jack W. Cumming joins TransMed7, LLC as a member of the Board of Directors.

7/5/2017:  TransMed7 receives Notice of Allowance from the USPTO for Patent Application 13/853,806 for SpeedBird Soft Tissue biopsy Platform Technology.

7/1/2017:  Dr. Edgar D. Staren joins TransMed7 as President of the company.  Dr. Staren also joins as President of Martinet Medical, LLC, a subsidiary Project Company of TransMed7 focused on the development of a novel whole-lumpectomy technology platform medical device.

7/5/2017:  TransMed7 receives Notice of Allowance from the USPTO for Patent Application 13/853,806 for SpeedBird Soft Tissue biopsy Platform Technology.

3/26-3/30, 2017:  TransMed7 highlights its SpeedBird, Martinet and Cardinal technologies at the annual meeting of the American Society of Breast Surgeons (ASBrS) in Las Vegas.

2/22/2017:  TransMed7 receives Notice of Issuance for US Patent No. 9,592,035 for SpeedBird soft tissue biopsy platform technology.  The patent will be issued on March 14, 2017.

Announcements

Full Listing of News & Events